EECP therapy is a boon for long-term COVID patients
EECP is a
non-invasive approach that has been found to enhance cerebral and heart
perfusion. When EECP patients arrive at the clinic, they lie down on a
treatment table and have three sets of pneumatic cuffs placed on their calves,
thighs, and lower hips. The mechanism for the cuffs to consecutively inflate
from the legs up to the hips during the heart's resting phase is a three-lead
electrocardiogram. The cuffs deflate simultaneously with the heart's beginning
of the contraction phase. The heart muscle and the rest of the body are both
subjected to the regulated inflation and deflation. A patient may have up to 35
therapy sessions over the course of a week, each lasting an hour.
New research
demonstrates that extended COVID, a condition that affects endothelial function
and vascular health, is a disease. EECP is a non-invasive, disease-modifying
treatment that has been proved in controlled clinical trials to enhance
endothelial function.
Worldwide,
an estimated 50% of COVID-19 patients have symptoms that continue six months
after the acute phase of the infection, with the severity of the long-term
symptoms varying.
The
difference from baseline for patients with long COVID alone was significant for
all endpoints, according to the researchers, and there was no discernible
distinction between patients with long COVID without CAD and those with CAD.
If you or
your family member facing the long COVID side effects; then you can should
contact us and consult our expert doctors.
For more
detailed information follow our website: www.shanikupaheartcare.com
Dr. Nikita Khabale
Patil
M.D.
Comments
Post a Comment